Retour
Également cotée sous
UNLYF
OTC
Fourchette du Jour
60,47 €
61,17 €
Fourchette 52 Semaines
60,47 €
74,98 €
Volume
3 212 451
Moyenne 50J / 200J
68,28 €
/
68,29 €
Clôture Précédente
61,07 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Consumer Defensive (329 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 14,0 | 10,5 |
| P/B | 8,5 | 1,2 |
| ROE % | 53,3 | 12,3 |
| Net Margin % | 18,8 | 5,3 |
| Rev Growth 5Y % | -0,9 | 5,5 |
| D/E | 1,9 | 0,6 |
Objectif de Cours des Analystes
Hold
65,55 €
+8.1%
Low: 60,10 €
High: 71,00 €
P/E Prévisionnel
19,5
BPA Prévisionnel
3,13 €
Croissance BPA (est.)
+0,0%
CA Est.
51 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,11 €
4,00 € – 4,28 €
|
62 B | 2 |
| FY2029 |
3,83 €
3,73 € – 4,00 €
|
58 B | 4 |
| FY2028 |
3,57 €
3,48 € – 3,72 €
|
55 B | 3 |
Insider Trading Activity
12 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 |
PEPPING KAREN K
Senior VP & CAO
|
grant | 4 | — | — |
| Mar 3, 2026 |
Dadakis Alex
See Remarks
|
other | 12 285 | — | — |
| Sep 8, 2025 |
Robinson Ryan D
Executive VP & CFO
|
grant | 37 | — | — |
| Sep 8, 2025 |
Kini Vikram
|
grant | 5 | — | — |
| May 20, 2025 |
DOLLIVE JAMES P
|
grant | 2 787 | — | — |
| May 8, 2025 |
Uggetti Alberto
EVP & CCO
|
sell | 1 961 | 70,00 € | 137 270 € |
| Apr 1, 2025 |
Zhou Weifang
See Remarks
|
grant | 16 951 | 57,85 € | — |
| Apr 1, 2025 |
Zhou Weifang
See Remarks
|
other | 71 657 | 13,15 € | — |
| Apr 1, 2025 |
Dadakis Alex
See Remarks
|
grant | 5 185 | — | — |
| Apr 1, 2025 |
PEPPING KAREN K
Senior VP & CAO
|
grant | 3 307 | 57,85 € | — |
| Apr 1, 2025 |
PEPPING KAREN K
Senior VP & CAO
|
other | 1 179 | 57,85 € | 68 205 € |
| Mar 27, 2025 |
Foundation Holdco LP
10% Owner
|
buy | 3 900 000 | — | — |
Points Clés
Revenue declined -0,94% annually over 5 years
Earnings grew 64,85% over the past year
ROE of 53,33% indicates high profitability
Net margin of 18,75% shows strong profitability
Generating 6,25B in free cash flow
P/E of 13,99 — trading at a low valuation
Croissance
Revenue Growth (5Y)
-0,94%
Revenue (1Y)-16,88%
Earnings (1Y)64,85%
FCF Growth (3Y)-11,17%
Qualité
Return on Equity
53,33%
ROIC16,84%
Net Margin18,75%
Op. Margin20,05%
Sécurité
Debt / Equity
1,91
Current Ratio0,79
Interest Coverage10,30
Valorisation
P/E Ratio
13,99
P/B Ratio8,53
EV/EBITDA15,61
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -16,88% | Revenue Growth (3Y) | -7,95% |
| Earnings Growth (1Y) | 64,85% | Earnings Growth (3Y) | 20,82% |
| Revenue Growth (5Y) | -0,94% | Earnings Growth (5Y) | 11,85% |
| Profitability | |||
| Revenue (TTM) | 50,50B | Net Income (TTM) | 9,47B |
| ROE | 53,33% | ROA | 13,44% |
| Gross Margin | 100,00% | Operating Margin | 20,05% |
| Net Margin | 18,75% | Free Cash Flow (TTM) | 6,25B |
| ROIC | 16,84% | FCF Growth (3Y) | -11,17% |
| Safety | |||
| Debt / Equity | 1,91 | Current Ratio | 0,79 |
| Interest Coverage | 10,30 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 13,99 | P/B Ratio | 8,53 |
| P/S Ratio | 2,62 | PEG Ratio | 0,78 |
| EV/EBITDA | 15,61 | Dividend Yield | 0,04% |
| Market Cap | 132,47B | Enterprise Value | 158,12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 50,50B | 60,76B | 59,60B | 60,07B | 52,44B |
| Net Income | 9,47B | 5,74B | 6,49B | 7,64B | 6,05B |
| EPS (Diluted) | 2,66 | 2,29 | 2,56 | 2,99 | 2,32 |
| Gross Profit | 50,50B | 60,76B | 25,18B | 24,17B | 22,19B |
| Operating Income | 10,13B | 9,40B | 9,76B | 10,76B | 8,70B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 70,44B | 79,75B | 75,27B | 77,82B | 75,10B |
| Total Liabilities | 52,86B | 57,20B | 54,50B | 56,12B | 55,35B |
| Shareholders' Equity | 15,52B | 19,99B | 18,10B | 19,02B | 17,11B |
| Total Debt | 29,59B | 30,66B | 28,59B | 28,44B | 29,67B |
| Cash & Equivalents | 3,94B | 6,14B | 4,16B | 4,33B | 3,42B |
| Current Assets | 17,06B | 19,19B | 17,90B | 19,16B | 17,40B |
| Current Liabilities | 21,65B | 25,23B | 23,51B | 25,43B | 24,78B |